Phylonix Snags $1.25M Grant for Zebrafish Drug Interaction Test | GenomeWeb
NEW YORK (GenomeWeb News) — Phylonix Pharmaceuticals has received a Small Business Innovation Research Grant from the National Institute of General Medical Sciences that it will use to develop its drug-interaction testing technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.